Kazuyoshi Kuwano

6PUBLICATIONS
75CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Biological adaptationAllergyGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 27, 2026
Efficacy and safety of necitumumab and pembrolizumab combination therapy in advanced non-small-cell lung cancer with ≥50% PD-L1 expression: A nonrandomized phase II trial.

|Jun 18, 2024
Multicenter Pharmacokinetic and Pharmacodynamic Study of Pembrolizumab for Non-small-Cell Lung Cancer in Patients Aged 75 Years and Older.

Shigehiro Yagishita, Yuta Yamanaka, Takayasu Kurata

|Jan 02, 2024
Phase II Study of Durvalumab Immediately after Completion of Chemoradiotherapy in Unresectable Stage III Non-small Cell Lung Cancer: TORG1937 (DATE Study).

Shinji Nakamichi, Kaoru Kubota, Toshihiro Misumi

|Dec 06, 2022
Long-Term Efficacy and Clinical Remission After Benralizumab Treatment in Patients with Severe Eosinophilic Asthma: A Retrospective Study.

Takanori Numata, Jun Araya, Keitaro Okuda

|Apr 08, 2022
Real-World Effectiveness of Dupilumab for Patients with Severe Asthma: A Retrospective Study.

Takanori Numata, Jun Araya, Hanae Miyagawa

|Jun 11, 2021
Effectiveness of Switching Biologics for Severe Asthma Patients in Japan: A Single-Center Retrospective Study.

Takanori Numata, Jun Araya, Hanae Miyagawa

Pageof 1

Frequent Collaborators

3 joint publications

Takanori Numata

3 joint publications

Hanae Miyagawa

2 joint publications

Katsuhiko Naoki

2 joint publications

Yukio Hosomi